Search research articles
Contact Us
Filters
Showing results (11-20 of 43) with videos related to
Page
of 5
Sort By:
Cells
|
February 9, 2024
β<sub>2</sub>-Adrenoceptor Activation Favor Acquisition of Tumorigenic Properties in Non-Tumorigenic MCF-10A Breast Epithelial Cells
Dany Silva, Clara Quintas, Jorge Gonçalves, et al.
Recent Patents on Anti-Cancer Drug Discovery
|
November 10, 2017
Adenosine Receptor Ligands on Cancer Therapy: A Review of Patent Literature
Joana B Sousa, Paula Fresco, Carmen Diniz, et al.
Acta Medica Portuguesa
|
June 21, 2012
[Chronic medication in the perioperative period: usage profile and risk management]
Liliana Castanheira, Ana Palmeiro, Paula Fresco, et al.
Pharmacology Research & Perspectives
|
August 30, 2018
Vancomycin therapeutic drug monitoring and population pharmacokinetic models in special patient subpopulations
Joaquim F Monteiro, Siomara R Hahn, Jorge Gonçalves, et al.
Microscopy Research and Technique
|
June 24, 2008
Immunohistochemical characterization of adenosine receptors in rat aorta and tail arteries
Sandra Leal, Carlos Sá, Jorge Gonçalves, et al.
Cancer Chemotherapy and Pharmacology
|
August 15, 2014
The combination of Cl-IB-MECA with paclitaxel: a new anti-metastatic therapeutic strategy for melanoma
Ana S Soares, Vera M Costa, Carmen Diniz, et al.
Journal of Cancer Research and Clinical Oncology
|
March 25, 2014
Combination of Cl‑IB‑MECA with paclitaxel is a highly effective cytotoxic therapy causing mTOR‑dependent autophagy and mitotic catastrophe on human melanoma cells
Ana S Soares, Vera M Costa, Carmen Diniz, et al.
International Journal of Molecular Sciences
|
January 8, 2023
Activation of β-Adrenoceptors Promotes Lipid Droplet Accumulation in MCF-7 Breast Cancer Cells via cAMP/PKA/EPAC Pathways
Dany Silva, Katarzyna Kacprzak, Clara Quintas, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
September 17, 2013
Potentiation of cytotoxicity of paclitaxel in combination with Cl-IB-MECA in human C32 metastatic melanoma cells: A new possible therapeutic strategy for melanoma
Ana S Soares, Vera M Costa, Carmen Diniz, et al.
International Journal of Clinical Pharmacy
|
June 5, 2013
Online drug databases: a new method to assess and compare inclusion of clinically relevant information
Cristina Silva, Paula Fresco, Joaquim Monteiro, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 43) with videos related to
Sort By:
Page
of 5
Cells
|
February 9, 2024
β<sub>2</sub>-Adrenoceptor Activation Favor Acquisition of Tumorigenic Properties in Non-Tumorigenic MCF-10A Breast Epithelial Cells
Dany Silva, Clara Quintas, Jorge Gonçalves, et al.
Recent Patents on Anti-Cancer Drug Discovery
|
November 10, 2017
Adenosine Receptor Ligands on Cancer Therapy: A Review of Patent Literature
Joana B Sousa, Paula Fresco, Carmen Diniz, et al.
Acta Medica Portuguesa
|
June 21, 2012
[Chronic medication in the perioperative period: usage profile and risk management]
Liliana Castanheira, Ana Palmeiro, Paula Fresco, et al.
Pharmacology Research & Perspectives
|
August 30, 2018
Vancomycin therapeutic drug monitoring and population pharmacokinetic models in special patient subpopulations
Joaquim F Monteiro, Siomara R Hahn, Jorge Gonçalves, et al.
Microscopy Research and Technique
|
June 24, 2008
Immunohistochemical characterization of adenosine receptors in rat aorta and tail arteries
Sandra Leal, Carlos Sá, Jorge Gonçalves, et al.
Cancer Chemotherapy and Pharmacology
|
August 15, 2014
The combination of Cl-IB-MECA with paclitaxel: a new anti-metastatic therapeutic strategy for melanoma
Ana S Soares, Vera M Costa, Carmen Diniz, et al.
Journal of Cancer Research and Clinical Oncology
|
March 25, 2014
Combination of Cl‑IB‑MECA with paclitaxel is a highly effective cytotoxic therapy causing mTOR‑dependent autophagy and mitotic catastrophe on human melanoma cells
Ana S Soares, Vera M Costa, Carmen Diniz, et al.
International Journal of Molecular Sciences
|
January 8, 2023
Activation of β-Adrenoceptors Promotes Lipid Droplet Accumulation in MCF-7 Breast Cancer Cells via cAMP/PKA/EPAC Pathways
Dany Silva, Katarzyna Kacprzak, Clara Quintas, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
September 17, 2013
Potentiation of cytotoxicity of paclitaxel in combination with Cl-IB-MECA in human C32 metastatic melanoma cells: A new possible therapeutic strategy for melanoma
Ana S Soares, Vera M Costa, Carmen Diniz, et al.
International Journal of Clinical Pharmacy
|
June 5, 2013
Online drug databases: a new method to assess and compare inclusion of clinically relevant information
Cristina Silva, Paula Fresco, Joaquim Monteiro, et al.
Page
of 5